Related Experiment Video
Updated: May 10, 2025
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
8.8K
Cyclodextrin-Derived Macromolecular Therapies for Inflammatory Diseases.
Yige Tang1,2, Tao Guo1, Xuanran Wang3
1College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China.
Macromolecular Bioscience
|April 24, 2025
Summary
Cyclodextrins (CDs) and their derivatives show significant anti-inflammatory potential by interacting with disease-causing molecules. These versatile macromolecules offer promising therapeutic strategies for various inflammatory conditions.
Area of Science:
- Biochemistry
- Immunology
- Materials Science
Background:
- Inflammation is a critical defense but dysregulated responses drive disease.
- Bioactive macromolecules, especially cyclodextrins (CDs), show promise for anti-inflammatory therapies.
Purpose of the Study:
- To review cyclodextrins and their derivatives with anti-inflammatory properties.
- To elucidate the molecular mechanisms underlying their therapeutic effects.
- To discuss applications and future clinical translation.
Main Methods:
- Systematic review of literature on cyclodextrin-based anti-inflammatory agents.
- Analysis of host-guest interactions and chemical modifications of CDs.
- Evaluation of therapeutic applications and clinical challenges.
Main Results:
- Native CDs sequester inflammatory triggers like cholesterol crystals and proteins.
- Modified CDs neutralize inflammatory mediators and modulate immune cells.
- CDs show potential in treating diverse inflammatory conditions.
Conclusions:
- Cyclodextrins and their derivatives are potent anti-inflammatory agents.
- Further research is needed to optimize biocompatibility, delivery, and efficacy for clinical use.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
86
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
86
01:29Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
01:29Drugs for Treatment of Ulcerative Colitis in IBD
102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102